About Edgar
Clients turn to Edgar Matias for guidance around protecting, enforcing, and defending their intellectual property rights. An accomplished scientific researcher before beginning his law career, Edgar brings deep technical knowledge and sharp analytic skills to his practice.Before joining RSHC, Edgar was an associate attorney at a national law firm where he worked on a range of patent and trademark-related issues, including infringement complaints and defense, patent claim construction, patent prosecution, and licensing matters. He also has experience with matters related to Uniform Domain Name Resolution Dispute Policy and the Digital Millennium Copyright Act.Having studied biological engineering and physics at the Massachusetts Institute of Technology, Edgar previously was a researcher at Northwestern University Feinberg School of Medicine where he gained hands-on laboratory experience in early HIV-1 transmission studies and contributed to various research publications. He also was part of a research team at the Max Planck Institute in Germany, working on improving influenza vaccine production.
Clients turn to Edgar Matias for guidance around protecting, enforcing, and defending their intellectual property rights. An accomplished scientific researcher before beginning his law career, Edgar brings deep technical knowledge and sharp analytic skills to his practice.
Before joining RSHC, Edgar was an associate attorney at a national law firm where he worked on a range of patent and trademark-related issues, including infringement complaints and defense, patent claim construction, patent prosecution, and licensing matters. He also has experience with matters related to Uniform Domain Name Resolution Dispute Policy and the Digital Millennium Copyright Act.
Having studied biological engineering and physics at the Massachusetts Institute of Technology, Edgar previously was a researcher at Northwestern University Feinberg School of Medicine where he gained hands-on laboratory experience in early HIV-1 transmission studies and contributed to various research publications. He also was part of a research team at the Max Planck Institute in Germany, working on improving influenza vaccine production.